These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 33747322)

  • 1. COVID-19-Associated Acute Brain Dysfunction Related to Sepsis.
    Tong DM; Zhou YT; Wang YW
    J Clin Med Res; 2021 Feb; 13(2):82-91. PubMed ID: 33747322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.
    Rogers JP; Chesney E; Oliver D; Pollak TA; McGuire P; Fusar-Poli P; Zandi MS; Lewis G; David AS
    Lancet Psychiatry; 2020 Jul; 7(7):611-627. PubMed ID: 32437679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports.
    Najjar S; Najjar A; Chong DJ; Pramanik BK; Kirsch C; Kuzniecky RI; Pacia SV; Azhar S
    J Neuroinflammation; 2020 Aug; 17(1):231. PubMed ID: 32758257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 delirium and encephalopathy: Pathophysiology assumed in the first 3 years of the ongoing pandemic.
    Otani K; Fukushima H; Matsuishi K
    Brain Disord; 2023 Jun; 10():100074. PubMed ID: 37056914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
    Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
    Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encephalopathy in COVID-19 Patients.
    Shah P; Patel J; Soror NN; Kartan R
    Cureus; 2021 Jul; 13(7):e16620. PubMed ID: 34458032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study.
    Pun BT; Badenes R; Heras La Calle G; Orun OM; Chen W; Raman R; Simpson BK; Wilson-Linville S; Hinojal Olmedillo B; Vallejo de la Cueva A; van der Jagt M; Navarro Casado R; Leal Sanz P; Orhun G; Ferrer Gómez C; Núñez Vázquez K; Piñeiro Otero P; Taccone FS; Gallego Curto E; Caricato A; Woien H; Lacave G; O'Neal HR; Peterson SJ; Brummel NE; Girard TD; Ely EW; Pandharipande PP;
    Lancet Respir Med; 2021 Mar; 9(3):239-250. PubMed ID: 33428871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparison between SARS-CoV-2 and Gram-Negative Bacteria-Induced Hyperinflammation and Sepsis.
    Brandenburg K; Ferrer-Espada R; Martinez-de-Tejada G; Nehls C; Fukuoka S; Mauss K; Weindl G; Garidel P
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of Neurological Manifestations in Covid-19: A Review.
    Garg RK
    Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system.
    Williams A; Branscome H; Khatkar P; Mensah GA; Al Sharif S; Pinto DO; DeMarino C; Kashanchi F
    J Neurovirol; 2021 Oct; 27(5):667-690. PubMed ID: 34581996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, Clinical Characteristics, and Outcomes of Sepsis Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Versus Other Pathogens in Hospitalized Patients With COVID-19.
    Shappell CN; Klompas M; Kanjilal S; Chan C; Rhee C
    Crit Care Explor; 2022 May; 4(5):e0703. PubMed ID: 35783550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19: A Global Threat to the Nervous System.
    Koralnik IJ; Tyler KL
    Ann Neurol; 2020 Jul; 88(1):1-11. PubMed ID: 32506549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Identification of Acute Brain Dysfunction in Pediatric Sepsis and Septic Shock in the Electronic Health Record: A Comparison of Four Definitions in a Reference Dataset.
    Alcamo AM; Becker AE; Barren GJ; Hayes K; Pennington JW; Curley MAQ; Tasker RC; Balamuth F; Weiss SL; Fitzgerald JC; Topjian AA
    Pediatr Crit Care Med; 2024 Aug; 25(8):740-747. PubMed ID: 38738953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic Metabolic Encephalopathy in Hospitalized Patients with COVID-19.
    Frontera JA; Melmed K; Fang T; Granger A; Lin J; Yaghi S; Zhou T; Lewis A; Kurz S; Kahn DE; de Havenon A; Huang J; Czeisler BM; Lord A; Meropol SB; Troxel AB; Wisniewski T; Balcer L; Galetta S
    Neurocrit Care; 2021 Dec; 35(3):693-706. PubMed ID: 33725290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral sepsis is a complication in patients with Novel Corona Virus Disease (COVID-19).
    Liu D; Wang Q; Zhang H; Cui L; Shen F; Chen Y; Sun J; Gan L; Sun J; Wang J; Zhang J; Cai Q; Deng J; Jiang J; Zeng L
    Med Drug Discov; 2020 Dec; 8():100057. PubMed ID: 32838292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement.
    Beach SR; Praschan NC; Hogan C; Dotson S; Merideth F; Kontos N; Fricchione GL; Smith FA
    Gen Hosp Psychiatry; 2020; 65():47-53. PubMed ID: 32470824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial.
    Maskin LP; Olarte GL; Palizas F; Velo AE; Lurbet MF; Bonelli I; Baredes ND; Rodríguez PO
    Trials; 2020 Aug; 21(1):743. PubMed ID: 32843098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological Sequelae of COVID-19.
    Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
    J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.